Biotech Breakthroughs: Vaccines, Longevity, and AI
Kilder
- Fierce Biotech: OSE turns up the heat on ovarian cancer with phase 2 win - Fierce Biotech
- Nature: A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines - Nature
- News-medical: Boston Children's scientists create new booster-free mRNA vaccine strategy - News-Medical
- Medicalxpress: COVID-19 mRNA vaccine plus immune system enhancer may reduce need for repeated boosters, say researchers - Medical Xpress
- BioSpace: Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm - BioSpace
- Bioworld: Regulatory actions for May 22, 2026 - BioWorld News
- Bioworld: China’s new IIT rules expected to wipe out ‘gray market’ - BioWorld News
- Bioworld: EMA poised to be 4th regulator approving Boehringer’s Jascayd lung drug - BioWorld News
- Bioworld: Asgard’s AT-108 shows promise as immunotherapeutic - BioWorld News
- STAT: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion - statnews.com
- Podcast: The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data - Beyond Biotech - the podcast from Labiotech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.